# High Flow Nasal Cannula Therapy for Early Management of Acute Hypercapnic Cardiogenic Pulmonary Edema in the Emergency Department

> **NCT03883555** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 32 (actual)

## Conditions studied

- Acute Cardiogenic Pulmonary Edema
- Hypercapnic Respiratory Failure

## Interventions

- **DEVICE:** High flow nasal therapy (HFNT) : Optiflow™
- **DEVICE:** Non invasive ventilation (niv)

## Key facts

- **NCT ID:** NCT03883555
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-01
- **Primary completion:** 2016-09-01
- **Final completion:** 2016-09-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883555, "High Flow Nasal Cannula Therapy for Early Management of Acute Hypercapnic Cardiogenic Pulmonary Edema in the Emergency Department". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03883555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*